[
    "{\"step_by_step_thinking\": \"To determine if CPX-351 can be used for the treatment of tuberculosis, we need to examine the information provided in the relevant documents. After reviewing the documents, we can see that CPX-351 is a liposomal formulation of cytarabine and daunorubicin that has shown efficacy in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, there is no mention of CPX-351 being used or tested for the treatment of tuberculosis in any of the documents. Therefore, based on the available information, the answer is no, CPX-351 cannot be used for the treatment of tuberculosis.\", \"answer_choice\": \"B\"}"
]